Literature DB >> 19622822

Ancillary care for public health research in developing countries.

Adnan A Hyder1, Maria W Merritt.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19622822      PMCID: PMC4314939          DOI: 10.1001/jama.2009.1072

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Medical researchers' ancillary clinical care responsibilities.

Authors:  Leah Belsky; Henry S Richardson
Journal:  BMJ       Date:  2004-06-19

2.  The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects.

Authors:  Henry S Richardson; Leah Belsky
Journal:  Hastings Cent Rep       Date:  2004 Jan-Feb       Impact factor: 2.683

3.  Ancillary-care responsibilities in observational research: two cases, two issues.

Authors:  N Dickert; K DeRiemer; P E Duffy; L Garcia-Garcia; T K Mutabingwa; B J Sina; P Tindana; R Lie
Journal:  Lancet       Date:  2007-03-10       Impact factor: 79.321

4.  Gradations of researchers' obligation to provide ancillary care for HIV/AIDS in developing countries.

Authors:  Henry S Richardson
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

5.  The ancillary-care obligations of medical researchers working in developing countries.

Authors: 
Journal:  PLoS Med       Date:  2008-05-20       Impact factor: 11.069

  5 in total
  18 in total

1.  Ethical review of global short-term medical volunteerism.

Authors:  Matthew DeCamp
Journal:  HEC Forum       Date:  2011-06

Review 2.  Responsibilities to plan for ancillary care pose ethical challenges for nutrition research in the community setting.

Authors:  Maria W Merritt; Holly A Taylor
Journal:  J Nutr       Date:  2012-08-29       Impact factor: 4.798

3.  Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.

Authors:  Nicole Mamotte; Douglas Wassenaar; Jennifer Koen; Zaynab Essack
Journal:  BMC Med Ethics       Date:  2010-03-09       Impact factor: 2.652

4.  Health researchers' ancillary care obligations in low-resource settings: how can we tell what is morally required?

Authors:  Maria W Merritt
Journal:  Kennedy Inst Ethics J       Date:  2011-12

Review 5.  Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Authors:  J Scott Roberts; Wendy R Uhlmann
Journal:  Prog Neurobiol       Date:  2013-04-09       Impact factor: 11.685

Review 6.  A field training guide for human subjects research ethics.

Authors:  Maria W Merritt; Alain B Labrique; Joanne Katz; Mahbubur Rashid; Keith P West; Joan Pettit
Journal:  PLoS Med       Date:  2010-10-05       Impact factor: 11.069

7.  Social justice and HIV vaccine research in the age of pre-exposure prophylaxis and treatment as prevention.

Authors:  Theodore C Bailey; Jeremy Sugarman
Journal:  Curr HIV Res       Date:  2013-09       Impact factor: 1.581

8.  Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coast.

Authors:  Sassy Molyneux; Stephen Mulupi; Lairumbi Mbaabu; Vicki Marsh
Journal:  BMC Med Ethics       Date:  2012-06-22       Impact factor: 2.652

9.  Model for developing context-sensitive responses to vulnerability in research: managing ethical dilemmas faced by frontline research staff in Kenya.

Authors:  Sassy Molyneux; Priya Sukhtankar; Johnstone Thitiri; Rita Njeru; Kui Muraya; Gladys Sanga; Judd L Walson; James Berkley; Maureen Kelley; Vicki Marsh
Journal:  BMJ Glob Health       Date:  2021-07

10.  Engaging with research ethics in central Francophone Africa: reflections on a workshop about ancillary care.

Authors:  Tomi Tshikala; Bavon Mupenda; Pierre Dimany; Aime Malonga; Vicky Ilunga; Stuart Rennie
Journal:  Philos Ethics Humanit Med       Date:  2012-08-06       Impact factor: 2.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.